<DOC>
	<DOCNO>NCT02809378</DOCNO>
	<brief_summary>The incidence postoperative nausea vomiting ( PONV ) thyroidectomy show relatively high compare surgery , report incidence 65-75 % . PONV may increase patient discomfort , delay patient discharge , increase cost patient care , risk postoperative bleeding may potentially cause airway obstruction . It report maintenance anesthesia propofol-remifentanil sevoflurane-propofol-remifentanil decrease incidence PONV compare sevoflurane alone , fail demonstrate decrease incidence PONV 6-24 hr postoperative period patient undergoing thyroidectomy . Administration Palonosetron , newly develop 5-HT3 antagonist long half life ( 48 hr ) may decrease incidence PONV particularly period . The purpose study evaluate compare incidence PONV thyroidectomy three different anesthetic method , sevoflurane sevoflurane-propofol-remifentanil sevoflurane-propofol-remifentanil-palonosetron woman patient .</brief_summary>
	<brief_title>The Effects Anesthetic Techniques Palonosetron Administration Incidence PONV</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Thiopental</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>patient undergo thyroidectomy euthyroid status American Society Anesthesiology Physical status 1,2 Ideal body weight &gt; 130 % gastrointestinal disease prior administration antiemetic ( 24hr )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>